SG11202109928WA - Pharmaceutical composition for treating aortic aneurysm - Google Patents
Pharmaceutical composition for treating aortic aneurysmInfo
- Publication number
- SG11202109928WA SG11202109928WA SG11202109928WA SG11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA SG 11202109928W A SG11202109928W A SG 11202109928WA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- aortic aneurysm
- treating aortic
- treating
- aneurysm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019045333 | 2019-03-13 | ||
PCT/JP2020/011042 WO2020184703A1 (ja) | 2019-03-13 | 2020-03-13 | 大動脈瘤の治療用医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109928WA true SG11202109928WA (en) | 2021-10-28 |
Family
ID=72427139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109928W SG11202109928WA (en) | 2019-03-13 | 2020-03-13 | Pharmaceutical composition for treating aortic aneurysm |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220184058A1 (es) |
EP (1) | EP3939656A4 (es) |
JP (1) | JP7516345B2 (es) |
KR (1) | KR20210144657A (es) |
CN (1) | CN113316469A (es) |
BR (1) | BR112021018017A2 (es) |
CA (1) | CA3133209A1 (es) |
MX (1) | MX2021010987A (es) |
SG (1) | SG11202109928WA (es) |
TW (1) | TW202100155A (es) |
WO (1) | WO2020184703A1 (es) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
JPS572240A (en) | 1980-06-06 | 1982-01-07 | Sankyo Co Ltd | Ml-236b derivative |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
PH23486A (en) | 1982-11-22 | 1989-08-16 | Sanzoz Inc | Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof |
US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
JP2569746B2 (ja) | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
TW338037B (en) | 1995-10-05 | 1998-08-11 | Otsuka Pharma Co Ltd | Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition |
CN101193656B (zh) * | 2005-06-08 | 2011-03-02 | 兴和株式会社 | 甘油三酸酯降低剂 |
JP2007230884A (ja) * | 2006-02-28 | 2007-09-13 | Kowa Co | 脊柱管狭窄症の予防及び/又は治療剤 |
WO2013103148A1 (ja) * | 2012-01-05 | 2013-07-11 | 興和株式会社 | 側副血行路発達促進剤 |
JP6367581B2 (ja) * | 2014-03-18 | 2018-08-01 | 国立大学法人浜松医科大学 | 動脈瘤縮小剤 |
EP3682886A4 (en) | 2017-09-13 | 2021-06-09 | National University Corporation Hamamatsu University School of Medicine | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AORTIC ANEURISM |
-
2020
- 2020-03-13 EP EP20770836.3A patent/EP3939656A4/en active Pending
- 2020-03-13 TW TW109108402A patent/TW202100155A/zh unknown
- 2020-03-13 BR BR112021018017A patent/BR112021018017A2/pt unknown
- 2020-03-13 WO PCT/JP2020/011042 patent/WO2020184703A1/ja unknown
- 2020-03-13 SG SG11202109928W patent/SG11202109928WA/en unknown
- 2020-03-13 US US17/438,309 patent/US20220184058A1/en active Pending
- 2020-03-13 KR KR1020217019386A patent/KR20210144657A/ko unknown
- 2020-03-13 JP JP2021505156A patent/JP7516345B2/ja active Active
- 2020-03-13 CN CN202080009881.7A patent/CN113316469A/zh active Pending
- 2020-03-13 MX MX2021010987A patent/MX2021010987A/es unknown
- 2020-03-13 CA CA3133209A patent/CA3133209A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2020184703A1 (ja) | 2020-09-17 |
CA3133209A1 (en) | 2020-09-17 |
EP3939656A4 (en) | 2022-12-07 |
US20220184058A1 (en) | 2022-06-16 |
KR20210144657A (ko) | 2021-11-30 |
BR112021018017A2 (pt) | 2021-11-23 |
JP7516345B2 (ja) | 2024-07-16 |
MX2021010987A (es) | 2021-12-15 |
EP3939656A1 (en) | 2022-01-19 |
TW202100155A (zh) | 2021-01-01 |
JPWO2020184703A1 (es) | 2020-09-17 |
CN113316469A (zh) | 2021-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201911928D0 (en) | Pharmaceutical compounds | |
GB201911517D0 (en) | Pharmaceutical composition | |
IL290843A (en) | A submucosal bioresorbable drug release platform | |
IL289213A (en) | A pharmaceutical preparation for tumor treatment | |
GB201911944D0 (en) | Pharmaceutical compounds | |
GB2584277B (en) | Dental stent | |
GB201914910D0 (en) | Pharmaceutical compounds | |
IL291570A (en) | Pharmaceutical preparations | |
GB201807053D0 (en) | Pharmaceutical composition | |
EP3682886A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AORTIC ANEURISM | |
SG11202103374TA (en) | Pharmaceutical composition | |
SG11202109928WA (en) | Pharmaceutical composition for treating aortic aneurysm | |
SG11202110315SA (en) | Pharmaceutical composition | |
IL278964A (en) | Pharmaceutical compositions for the treatment of sphingomyelinic acid deficiency | |
PL3908321T3 (pl) | Kompozycja farmaceutyczna | |
SG11202105231UA (en) | Pharmaceutical composition for treating wounds | |
KR102324922B9 (ko) | 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물 | |
GB201915932D0 (en) | Pharmaceutical compounds | |
GB201915273D0 (en) | Pharmaceutical compounds | |
EP3461490C0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEMORRHOIDAL DISEASES | |
IL285728A (en) | Pharmaceutical composition | |
EP3782603C0 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING GOUT | |
GB201912686D0 (en) | Pharmaceutical composition | |
GB201908003D0 (en) | Pharmaceutical composition | |
EP3993801A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INSOMNIA |